AKSO HEALTH GROUP (AHG)
US98422P1084 - ADR
Taking everything into account, AHG scores 3 out of 10 in our fundamental rating. AHG was compared to 109 industry peers in the Health Care Providers & Services industry. No worries on liquidiy or solvency for AHG as it has an excellent financial health rating, but there are worries on the profitability. AHG is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
AHG had negative earnings in the past year.
In the past year AHG had a positive cash flow from operations.
AHG had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: AHG reported negative operating cash flow in multiple years.
1.2 Ratios
AHG has a worse Return On Assets (-6.66%) than 64.81% of its industry peers.
AHG has a Return On Equity (-6.84%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.66% | ||
| ROE | -6.84% | ||
| ROIC | N/A |
ROA(3y)-13.47%
ROA(5y)-47.73%
ROE(3y)-53.44%
ROE(5y)-101.9%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of AHG (5.06%) is worse than 80.56% of its industry peers.
The Profit Margin and Operating Margin are not available for AHG so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 5.06% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
Compared to 1 year ago, AHG has an improved debt to assets ratio.
2.2 Solvency
AHG has an Altman-Z score of 73.19. This indicates that AHG is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of AHG (73.19) is better than 100.00% of its industry peers.
AHG has a debt to FCF ratio of 1.48. This is a very positive value and a sign of high solvency as it would only need 1.48 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 1.48, AHG belongs to the best of the industry, outperforming 87.04% of the companies in the same industry.
A Debt/Equity ratio of 0.01 indicates that AHG is not too dependend on debt financing.
AHG's Debt to Equity ratio of 0.01 is amongst the best of the industry. AHG outperforms 82.41% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 1.48 | ||
| Altman-Z | 73.19 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
AHG has a Current Ratio of 39.52. This indicates that AHG is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 39.52, AHG belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
A Quick Ratio of 39.46 indicates that AHG has no problem at all paying its short term obligations.
AHG's Quick ratio of 39.46 is amongst the best of the industry. AHG outperforms 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 39.52 | ||
| Quick Ratio | 39.46 |
3. Growth
3.1 Past
The earnings per share for AHG have decreased strongly by -220.05% in the last year.
AHG shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -81.71%.
AHG shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.18% yearly.
EPS 1Y (TTM)-220.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.8%
Revenue 1Y (TTM)-81.71%
Revenue growth 3YN/A
Revenue growth 5Y-8.18%
Sales Q2Q%16.16%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
AHG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
The rest of the industry has a similar Price/Free Cash Flow ratio as AHG.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 298.11 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for AHG!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AKSO HEALTH GROUP
NASDAQ:AHG (12/18/2024, 9:47:12 AM)
1.6724
-0.17 (-9.11%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap402.82M
Analysts
Price Target
Short Float %
Short Ratio
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.66% | ||
| ROE | -6.84% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 5.06% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.02
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 39.52 | ||
| Quick Ratio | 39.46 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-220.05%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-81.71%
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y